Penn Davis McFarland’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-374,068
| Closed | -$13.6M | – | 44 |
|
|
2016
Q4 | $13.6M | Sell |
374,068
-2,625
| -0.7% | -$95.2K | 3.72% | 9 |
|
|
2016
Q3 | $17.3M | Sell |
376,693
-2,003
| -0.5% | -$92.2K | 4.44% | 8 |
|
|
2016
Q2 | $19M | Buy |
378,696
+103,800
| +38% | +$5.21M | 5.06% | 6 |
|
|
2016
Q1 | $14.7M | Sell |
274,896
-7,774
| -3% | -$416K | 3.86% | 12 |
|
|
2015
Q4 | $18.6M | Sell |
282,670
-1,082
| -0.4% | -$71K | 4.66% | 9 |
|
|
2015
Q3 | $16M | Sell |
283,752
-12,086
| -4% | -$682K | 4.22% | 10 |
|
|
2015
Q2 | $17.5M | Sell |
295,838
-20,810
| -7% | -$1.23M | 4.07% | 9 |
|
|
2015
Q1 | $19.7M | Sell |
316,648
-7,922
| -2% | -$494K | 4.17% | 8 |
|
|
2014
Q4 | $19.2M | Sell |
324,570
-24,749
| -7% | -$1.46M | 4.2% | 8 |
|
|
2014
Q3 | $18M | Sell |
349,319
-3,660
| -1% | -$189K | 3.92% | 9 |
|
|
2014
Q2 | $19.2M | Sell |
352,979
-1,369
| -0.4% | -$74.5K | 3.76% | 10 |
|
|
2014
Q1 | $18.7M | Buy |
354,348
+21,903
| +7% | +$1.16M | 3.97% | 11 |
|
|
2013
Q4 | $13.3M | Sell |
332,445
-43,450
| -12% | -$1.74M | 3.2% | 13 |
|
|
2013
Q3 | $14.2M | Buy |
375,895
+5,970
| +2% | +$226K | 3.39% | 14 |
|
|
2013
Q2 | $14.5M | Buy |
+369,925
| New | +$14.5M | 3.44% | 14 |
|